FT Vest美國股票深度緩衝主動型ETF-3月 DMAR 深 滬
等待開盤 03-26 09:30:00 美东时间
42.44
+0.040
+0.09%
華盛通- 最 高42.60
- 今 開42.55
- 成交量 47.17万股
- 最 低 42.42
- 昨 收 42.40
- 總市值 3.82亿
- 52周最高 42.74
- 市盈率 靜 --
- 換手率 5.24%
- 52周最低 35.0694
- 委 比 -25.00%
- 總股本 900.00万
- 歷史最高 42.74
- 量 比 3.22
- 振 幅 0.42%
- 歷史最低 29.15
- 每 手 1
- 風險率 1.56%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Fennec Pharmaceuticals (FENC) to release Q4 earnings on March 24. Analysts expect EPS of $0.04 and revenue of $14.73 million. Stock gained 1.8% on Monday.
03-24 04:40
Fennec Pharmaceuticals Settles PEDMARK Patent Litigation With Cipla; Blocking Generic Entry Until September 2033
Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement with Cipla Limited and Cipla USA, Inc. to settle the litigation between them
03-16 20:13
Fennec Pharmaceuticals settles PEDMARK patent litigation with Cipla, bars generic entry until Sept. 1, 2033
Fennec Pharmaceuticals settles PEDMARK patent litigation with Cipla, bars generic entry until Sept. 1, 2033 Fennec said it reached a settlement with Cipla to resolve litigation over Cipla’s FDA application to market a generic version of PEDMARK. Under the agreement, the lawsuit will be dismissed and
03-16 20:08
Avenue Supermarts Vests 1.51 Million ESOPs Under 2016 Scheme
Avenue Supermarts Ltd. ( ($IN:DMART) ) has provided an update. Avenue Supermart...
03-15 00:33
DMart Parent Avenue Supermarts Names Kalpana Unadkat as Chairperson from April 2026
Avenue Supermarts Ltd. ( ($IN:DMART) ) just unveiled an update. Avenue Supermar...
03-15 00:33
Avenue Supermarts Updates Key Executives Authorized for Market Disclosures
Avenue Supermarts Ltd. ( ($IN:DMART) ) has shared an update. Avenue Supermarts ...
03-15 00:32
BRIEF-Safeture Signs Five-Year Contract Valued At About SEK 23 Mln
BRIEF-Safeture Signs Five-Year Contract Valued At About SEK 23 Mln March 4 (Reuters) - Safeture AB SFTR.ST : SAFETURE SECURES LANDMARK FIVE-YEAR AGREEMENT WITH GLOBAL HEALTH AND SECURITY LEADER SIGNS FIVE-YEAR CONTRACT VALUED AT ABOUT SEK 23 MILLION Source text: ID:nPn9mfwQ9a Further company coverag
03-04 22:05
Fennec Pharma Backs Real-World Study Of PEDMARK To Protect Hearing In Cancer Patients
Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a specialty pharmaceutical company, today announced that the Tampa General Hospital (TGH) Cancer Institute is initiating a study evaluating the real-world clinical
03-04 20:09
BRIEF-Jakks Pacific And Vtuber Ironmouse Announce Landmark Collaboration To Launch Products Inspired By The Popular Twitch Streamer
BRIEF-Jakks Pacific And Vtuber Ironmouse Announce Landmark Collaboration To Launch Products Inspired By The Popular Twitch Streamer March 3 (Reuters) - JAKKS Pacific Inc JAKK.O : JAKKS PACIFIC AND VTUBER IRONMOUSE ANNOUNCE LANDMARK COLLABORATION TO LAUNCH PRODUCTS INSPIRED BY THE POPULAR TWITCH STRE
03-03 22:07
BRIEF-Vanda Announces FDA Grants Landmark Hearing For Hetlioz® In Jet Lag Disorder, The First Drug Approval Hearing In Over 40 Years
BRIEF-Vanda Announces FDA Grants Landmark Hearing For Hetlioz® In Jet Lag Disorder, The First Drug Approval Hearing In Over 40 Years March 3 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O : VANDA ANNOUNCES FDA GRANTS LANDMARK HEARING FOR HETLIOZ® IN JET LAG DISORDER, THE FIRST DRUG APPROVAL HEARING IN
03-03 21:11
